Kosack, Lindsay <br/><br/>
The ERBB-STAT3 Axis Drives Tasmanian Devil Facial Tumor Disease.  [electronic resource] 

 -  Cancer cell  01 2019 
 - 125-139.e9 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1878-3686 
<br/><br/><label>Standard No.: </label>10.1016/j.ccell.2018.11.018  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>DNA Methylation<br/>Drug Screening Assays, Antitumor<br/>ErbB Receptors--metabolism<br/>Facial Neoplasms--drug therapy<br/>Gene Expression Regulation, Neoplastic--drug effects<br/>Histocompatibility Antigens Class I--metabolism<br/>Marsupialia<br/>Mice<br/>Phosphorylation<br/>Proteomics--methods<br/>STAT3 Transcription Factor--metabolism<br/>Signal Transduction<br/>Small Molecule Libraries--administration & dosage<br/>Xenograft Model Antitumor Assays